| Laurel Bay Health & Rehabilitation Center | |
| 32 Laurel Avenue, Keansburg, New Jersey 07734 | |
| (732) 787-8100 | |
| Name | Laurel Bay Health & Rehabilitation Center |
|---|---|
| Location | 32 Laurel Avenue, Keansburg, New Jersey |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 123 |
| Occupancy Rate | 67.24% |
| Medicare ID (CCN) | 315437 |
| Legal Business Name | Laurel Bay Health And Rehabilitation Center |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1043370596 |
| Organization Name | LAUREL BAY HEALTH AND REHABILITATION CENTER |
| Doing Business As | BEACHVIEW CARE AND REHAB CENTER |
| Address | 32 Laurel Ave, Keansburg, NJ 07734 |
| Phone Number | 732-787-8100 |
News Archive
The nation's first FDA-approved cancer treatment vaccine, Provenge, is being offered for the first time in Western New York at Roswell Park Cancer Institute.
Lucideon, the international materials development and consultancy organization, is pleased to announce that Biodensol will be holding a symposium entitled, ‘Novel Silicate and Phosphate Materials for Bone and Tooth Restoration' on Tuesday 07 November 2017, 09:00-16:15 at its headquarters in Stoke-on-Trent.
Metabolic changes responsible for the evolution of our unique cognitive abilities indicate that the brain may have been pushed to the limit of its capabilities. Research published today in BioMed Central's open access journal Genome Biology adds weight to the theory that schizophrenia is a costly by-product of human brain evolution.
The Japanese version of the Ford Insomnia Response to Stress Test has been validated and confirmed as a reliable tool for assessing vulnerability to insomnia in healthy individuals.
ProActive Capital Resources Group, a company dedicated to the discovery and creation of value in the small and micro-cap marketplace, is proud to announce client presentations at the 3rd Annual OneMedForum held in San Francisco, January 12-13, 2010. ProActive clients presenting are: Access Pharmaceuticals, ImmunoCellular Therapeutics, DataTrak International, Quantum Immunologics, with Protox Therapeutic's presentation pending.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
The nation's first FDA-approved cancer treatment vaccine, Provenge, is being offered for the first time in Western New York at Roswell Park Cancer Institute.
Lucideon, the international materials development and consultancy organization, is pleased to announce that Biodensol will be holding a symposium entitled, ‘Novel Silicate and Phosphate Materials for Bone and Tooth Restoration' on Tuesday 07 November 2017, 09:00-16:15 at its headquarters in Stoke-on-Trent.
Metabolic changes responsible for the evolution of our unique cognitive abilities indicate that the brain may have been pushed to the limit of its capabilities. Research published today in BioMed Central's open access journal Genome Biology adds weight to the theory that schizophrenia is a costly by-product of human brain evolution.
The Japanese version of the Ford Insomnia Response to Stress Test has been validated and confirmed as a reliable tool for assessing vulnerability to insomnia in healthy individuals.
ProActive Capital Resources Group, a company dedicated to the discovery and creation of value in the small and micro-cap marketplace, is proud to announce client presentations at the 3rd Annual OneMedForum held in San Francisco, January 12-13, 2010. ProActive clients presenting are: Access Pharmaceuticals, ImmunoCellular Therapeutics, DataTrak International, Quantum Immunologics, with Protox Therapeutic's presentation pending.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 16.3 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.42 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 22.62 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.12 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 20.81 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 0.85 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 91.17 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 9.22 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 60.8 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.39 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 24.35 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 26.69 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 15.25 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 95.73 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 52.24 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 81.63 | 82.93 |
News Archive
The nation's first FDA-approved cancer treatment vaccine, Provenge, is being offered for the first time in Western New York at Roswell Park Cancer Institute.
Lucideon, the international materials development and consultancy organization, is pleased to announce that Biodensol will be holding a symposium entitled, ‘Novel Silicate and Phosphate Materials for Bone and Tooth Restoration' on Tuesday 07 November 2017, 09:00-16:15 at its headquarters in Stoke-on-Trent.
Metabolic changes responsible for the evolution of our unique cognitive abilities indicate that the brain may have been pushed to the limit of its capabilities. Research published today in BioMed Central's open access journal Genome Biology adds weight to the theory that schizophrenia is a costly by-product of human brain evolution.
The Japanese version of the Ford Insomnia Response to Stress Test has been validated and confirmed as a reliable tool for assessing vulnerability to insomnia in healthy individuals.
ProActive Capital Resources Group, a company dedicated to the discovery and creation of value in the small and micro-cap marketplace, is proud to announce client presentations at the 3rd Annual OneMedForum held in San Francisco, January 12-13, 2010. ProActive clients presenting are: Access Pharmaceuticals, ImmunoCellular Therapeutics, DataTrak International, Quantum Immunologics, with Protox Therapeutic's presentation pending.
› Verified 7 days ago
Laurel Bay Health & Rehabilitation Center Location: 32 Laurel Avenue, Keansburg, New Jersey 07734 Phone: (732) 787-8100 |